3COIAO A, DI SARNO A, CAPPABIANCA P, et al. With- drawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia [J]. N Eng J Med, 2003, 349:2023 -2033.
2GutzmenJH,Rugowski DE,Schroeder MD,et al.Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells[J].Mol Endocrinol,2004,18 : 3064.
3Gourdji D ,Laverriere JN.The rat prolactin gene:a target for tissuespecific and hormone-dependent transcription faetors[J].Mol Cell Endoerinol, 1994,100 : 133.
4Ben-Jonathan N, Mershon JL, Allen DL,et al.Extrapituitary prolactin: distribution,regulation ,functions and chnical aspects[J].Endocr Rev, 1996,17:639.
5Freeman ME, Kanyicska B, Lerant A, et al.Prolactin:structure, function, and regulation of secretion[J].Physiol Rev, 2000,80:1523.
6Watanabe K,Kessler CA,Bachurski CJ ,et al.ldentlfication of a deciduas-speciilc enhancer on the human prolactin gene with two critical activator protein 1 (AP- 1)binding sites[J].Mol Endocrinal, 2001, 15:638.
7Horseman ND.Prolactin receptor diversity in humans:novel isoforms suggest general principles[J].Trends Endocrinol Metab, 2002,13:47.
8Goffin V, Bernichtein S ,Touraine P,et al.Development and potential clinical uses of human prolactin receptor antagonists[J].Endecr Rev, 2005,26:400.
9Cuellar FG Bromocriptine mesylate(parlodel)in the management of amenorrhea/galactorrhea assciated with hyperprolactinemia.Obstet Gynecol,1980,55:278.
10Canales ES,Garcia IC,Ruiz JE,et al.Bromocriptine AS Prophylactic therapy in prolactionama during pregnancy.Fertil steril,1981,36:524.
1Srikumar BN, Raju TR, Shankaranarayana-Rao BS. Contras-ting effects of bromocriptine on learning of a partially baited ra- dial arm maze task in the presence and absence of restraint stress [ J ~. Psychopharmacology ( Berl), 2007, 193 ( 3 ) : 363 - 374.
2Hashizume T, Sawada T, Nakajima Y, et al. Bromocriptine inhibits salsolinol- induced prolactin release in male goats [J]. Anim Sci J, 2012, 83 (1) : 63-67.
